If the amorphous metal pacemaker prototype shell/can was more economical and of better prioperties in all metallic aspects. Then why did LQMT not take it to the shareholders of these companies. Do they not suffer too in share price?
After all why would the three largest selling pacemaker companies want to spend more money and why too would health insurance companies want to spend more of their premiums as well if they could save a few million each year?
There are a lot of points for concern and yours is just the tip of the iceberg!
Left in the dark? More like shoved into the black hole of our universe. Where the hard earned income of many has never seen the light of day for a long long time.
News 
Market Data 
Discover 
